A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis
Clinical trial NCT06660992 · RECRUITING
Trial details
- NCT number
- NCT06660992
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-30
- Primary completion
- 2026-11-28
- Enrollment
- 669
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.